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Objective: To investigate the effect of pre-existing Schistosoma haematobium
(S. haematobium) infection on malaria disease severity.
Methods: The study involved the use of twenty-ﬁve imprinting control region mice,
ﬁfteen of which were initially infected with S. haematobium. Five of the remaining ten
schisto-uninfected mice together with ﬁve schisto-infected mice were infected with
Plasmodium berghei (P. berghei) after four weeks (acute stage) of schistosoma infection.
The remaining ﬁve schisto-uninfected mice together with ﬁve schisto-infected mice were
also infected with P. berghei after seven weeks (chronic stage) of schistosoma infection.
The last ﬁve schisto-infected mice were used as control group. They were then monitored
for changes in P. berghei parasitaemia on Days 3, 5, 7, 9 and 11 post-infection. Records
on their survivability were also taken.
Results: The co-infected mice had signiﬁcantly higher malaria parasitaemia, compared
with the mono-infected mice during acute S. haematobium infection. In contrast, the co-
infected mice had signiﬁcantly lower malaria parasitaemia during chronic
S. haematobium infection and a higher survival rate.
Conclusions: Co-infection of mice with P. berghei during acute S. haematobium
infection resulted in rapid P. berghei development and increased malaria parasitaemia.
However, the co-infection resulted in slower P. berghei development and decreased
malaria parasitaemia with enhanced survivability of the mice during chronic
S. haematobium infection. Therefore, pre-existing chronic S. haematobium infection may
provide some protection to the host by reducing parasitaemia.1. Introduction
Schistosomiasis and malaria are the world's two most
important parasitic infections in terms of distribution, morbidity
and mortality [1]. Schistosomiasis and malaria are among the
parasitic infections that share common transmission areas in
various tropical regions. Recent studies in vertebrates have
indicated that interactions between co-infecting parasites canbe pronounced and have important consequences for disease
development, severity and transmission dynamics [2,3].
Therefore, there is the need to determine how a given parasite
will interact with another in the same host. It will show
whether the presence of one parasite in the host hinders the
activities of the other.
Although interactions between helminthes and malaria par-
asites could affect both parties, research has mostly focused on
the extent to which helminth co-infection inﬂuences the malarial
disease. In the past few years, studies have been conducted to
elucidate the immune mechanism(s) involved in worm and
malaria co-infections [4,5]. However, many of these studies have
produced conﬂicting results, which has made it difﬁcult to
clearly understand the outcomes of these co-infections [5–14].
Some studies have reported an increased incidence ofn open access article under the CC BY-NC-ND
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(S. mansoni) [6,10], while other studies have indicated that
Schistosoma haematobium (S. haematobium) provides some
protection from malaria such as lower parasitaemia and lower
incidence [7–9].
Speculations on how helminthic infections may alter the
susceptibility to clinical malaria have led to an increasing in-
terest in investigating the consequences of co-infection. These
studies have yielded contrasting results. Earlier studies reported
a decreased malaria parasitaemia in co-infected mice whereas a
recent one reported that mice with ova producing S. mansoni
infection had increased malaria parasitaemia with Plasmodium
infection [8,10–13].
Most studies that examined naturally occurring co-infection
in humans indicated that co-infection with schistosoma and
malaria parasites had an effect on the host, both in terms of
pathological and immunological responses [14]. The direction of
this response seems to depend on the host age, the malaria
parasitaemia, the species of schistosome and the worm burden.
Co-infection by these two parasites may have an important in-
ﬂuence on the regulation of the immune response associated
with the development of these infections and their respective
morbidity [5,15,16].
Over the years, it has been more progressively speculated that
helminth infections may change vulnerability to clinical malaria,
and there is now escalating interest in investigating the reper-
cussion of co-infection, with studies producing contrasting re-
sults [7–13]. Therefore, this study seeks to investigate the effect of
pre-existing S. haematobium infection on malaria severity, using
experimental animal model. Findings from our study will help to
provide explanation to the observed trend of vulnerability or
protection that pre-existing infection offers to new infections.
2. Materials and methods
2.1. Source of imprinting control region (ICR) mice
Male ICR mice, four weeks old, were purchased from the
Noguchi Memorial Institute for medical research animal's house.
They were kept in the animal facility at University of Cape
Coast. Mice were maintained in ventilated cages and supplied
with standard food and distilled water. The mice were randomly
assigned to ﬁve groups, with each group containing ﬁve mice.
The studies were conducted in accordance with accepted prin-
ciples for laboratory animal use and care (EU directive of 1986:
86/609/EEC). Approval for this study was obtained from the
Department of Biomedical and Forensic Sciences Ethical
Committee.
2.2. Source of the helminthes and parasites inoculation
Infected Bulinus truncatus snails were collected from Baa-
ﬁkrom, a town near Mankessim, Central Region, Ghana. The
snails were exposed to sunlight for about 30 min to shed their
cercariae into clean water in Petri dish and checked for the
presence and species of the cercariae using a dissecting micro-
scope at 40× magniﬁcation to discriminate S. haematobium
cercariae from bird and other animal schistosomes. Cercariae
from different shedding dish (Petri dish) were pooled into test
tubes and centrifuged at a low speed of 800 r/min (revolution per
minute) using Centrifuge 5702 R to concentrate the cercariaeand allow mixing of sexes to avoid the possibility of single
infection. The sediments were then collected and used to infect
the mice. About 50–100 cercariae were percutaneously injected
into each mouse with 2 mL syringe, for three groups of mice
(Groups 1, 2 and 3). Groups 4 and 5 mice were not infected with
cercariae. Helminth infection was conﬁrmed by the presence of
worms by portal perfusion after four weeks [17].
Plasmodium berghei (P. berghei) was provided from
Noguchi Memorial Institute for medical research (Legon,
Ghana). Parasites were stored as frozen stabilates at −80C. To
obtain experimental inocula of P. berghei, packed red blood
cells were passed through four donor mice. Infections were
initiated in ICR mice by intraperitoneal injection of 0.2 mL of
blood (packed red blood cells) containing 1.0 × 106 of
P. berghei after four weeks of S. haematobium infection for
Group 1 mice and Group 4 mice. After seven weeks of
S. haematobium infection, Groups 2 and 5 mice were also
inoculated with 1.0 × 106 of P. berghei. Group 3 mice served as
control for the chronic infection. The various treatment groups
were monitored for parasite development and growth in the mice
[18].
2.3. Parasitaemia determination
Thin blood ﬁlms from tail blood were made using standard
microscope slides on Days 3, 5, 7, 9 and 11, air-dried and ﬁxed
in an absolute methanol for 5 min. The stained blood ﬁlms were
observed under a standard light microscope with 100× oil im-
mersion lens. Infected and uninfected erythrocytes in different
ﬁelds of view were identiﬁed and counted. Infected red blood
cells were counted microscopically in at least ﬁve microscopic
ﬁelds, each showing approximately 300 cells [10,17].
2.4. Mice survivability
Mice were monitored daily for mortality, to evaluate the
survival rate of schistosome mono-infected, P. berghei mono-
infected and the co-infected mice for both acute and chronic
schistosome infection.
2.5. Statistical analysis
Differences in the parameters measured for the different test
groups were tested for signiﬁcance by the independent t-test
using SPSS 17 computer software. Differences in between
groups were considered signiﬁcant when P value was less than
0.05. Percentage survivability were also used as comparing pa-
rameters for the different groups.
3. Results
3.1. Survivability
During the chronic co-infection, the P. berghei mono-
infected group of mice survived until Day 5 after which they
began to die on Day 6. Only 40% of them survived until Day 8
after which they also died before Day 11. On the other hand, the
Schistosoma–Plasmodium co-infected group survived until Day
6 when they started to die. Eighty percent of them survived until
Day 12 after which they all died by Day 14 (Figure 1). In
Figure 2. Length of survivability in Schistosoma–Plasmodium co-infected,
P. berghei mono-infected mice and S. haematobium mono-infected mice
during acute schistosome infection.
CO4: 4th week co-infected group; PbO: P. berghei mono-infected group;
SO4: 4th week S. haematobium mono-infected group.
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during the entire experiment (Figures 1 and 2).
However, during the acute co-infection, the co-infected mice
started to die on Day 7, whilst the P. berghei mono-infected
mice started to die on Day 5, with all mono infected mice
dying by Day 10 after P. berghei infection. But, all the co-
infected group died by Day 11 (Figure 2).
3.2. Malaria parasitaemia
During the acute stage of infection, malaria parasitaemia was
determined on Day 3 in both single and co-infected group. On
Day 3 after P. berghei infection, the Plasmodium mono-infected
group developed a parasitaemia of 10.70% ± 0.26% whilst, the
co-infected group developed a parasitaemia of 18.60% ± 0.21%
(P < 0.01). The parasitaemia increased to 28.75% ± 0.19% and
23.78% ± 0.17% at Day 5 for both the co-infected and Plas-
modium mono-infected group respectively (P < 0.05). However,
the parasitaemia peaked at Day 9 for both groups with
52.61% ± 0.19% and 51.71% ± 0.15% for the co-infected and
mono-infected mice (P < 0.05). All the infected mice were dead
by Day 11, thus no parasitaemia was recorded for Day 11 during
acute schistosome infection (Figure 3).
Infection of mice with P. berghei seven weeks post-
S. haematobium infection resulted in slower development of
malaria parasite and decreased malaria parasitaemia than
P. berghei mono-infected mice which was in contrast to the
acute infections. The co-infected group of mice had parasitaemia
of 8.95% ± 0.63% on Day 3, compared to 10.70% ± 0.74% in
the P. berghei mono-infected (P < 0.05). At Day 7, the co-
infected group developed a parasitaemia of 31.24% ± 0.05%
compared to that of the mono-infected group of 40.5% ± 0.27%
(P < 0.01). Both, co-infected and mono-infected mice recorded a
peak parasitaemia of 49.58% ± 0.24% and 51.72% ± 0.28%
respectively (P = 0.032) at Day 9. Finally, the co-infected mice
experienced a reduction in parasitaemia (36.91% ± 0.40%) onFigure 1. Length of survivability in Schistosoma–Plasmodium co-infected,
P. berghei mono-infected mice and S. haematobium mono-infected mice
during chronic schistosome infection.
CO7: 7th week co-infected group; PbO: P. berghei mono-infected group;
SO7: 7th week S. haematobium mono-infected group.Day 11. However, all the mono infected mice were dead by Day
11 (Figure 3).Figure 3. P. berghei parasitaemia in mice co-infected with P. berghei 4
weeks and 7 weeks post-S. haematobium infection and in mice infected
with P. berghei only.
CO4: 4th week co-infected; CO7: 7th week co-infected; PbO: P. berghei
mono-infected.4. Discussion
Many studies have been carried out to examine the impact of
S. mansoni infection on malaria severity, both in mouse models
and in humans, yet the results are limited and often conﬂicting.
In this study, our aim was to investigate the effect of pre-existing
S. haematobium infection on malaria disease severity in mice.
This is also the ﬁrst study in Ghana to document the impact of
acute and chronic pre-existing S. haematobium infection on
malaria disease severity in mice.
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S. haematobium post infection with P. berghei co-infection
favoured rapid P. berghei development and increased
P. berghei parasitaemia than mice with P. berghei infection
only. However, mice with 7 weeks (chronic stage)
S. haematobium post infection with P. berghei co-infection was
found to slow down P. berghei development and reduced
P. berghei parasitaemia than mice with P. berghei only. This is
in agreement with other studies which indicated that
S. haematobium provided some protection from malaria [5,7,8].
This ﬁnding is also in agreement with observation by
Christensen et al. [19], who reported that the outcomes of
experimental co-infections with protozoan and trematode para-
sites depended on the parasite species as well as the relative
timing of infection. However, the ﬁndings is in contrast with a
number of previous studies which have demonstrated higher
malaria parasitaemia in mice co-infected with various species/
strains of rodent malaria and worms than those infected with the
malaria parasite alone. For instance, Bucher et al. [10], reported
increased malaria parasitaemia during early stages of malaria in
chronic S. mansoni–P. berghei co-infected mice than mono-
infected mice.
The rapid P. berghei development observed during the acute
stage of S. haematobium infection in the co-infected group of
mice appears to indicate that the acute post S. haematobium
infection predisposes the host to more stern infection. The
elevated P. berghei parasitaemia seen in S. haematobium–
P. berghei co-infected mice could be attributed to a schistosome
parasite induced Th2-mediated immune inhibition of the
P. berghei-induced Th1 response. This corroborate with ﬁndings
that malaria resistant mice have Th1 type protective immune
response against blood-stage P. berghei infection [20]. Lyke et al.
[9], revealed that the polarized Th2-enriched environment
induced by underlying schistosomiasis modulated the human
immune response, possibly affecting the incidence and severity
of concomitant falciparum malaria. The observed increase in
parasitaemia in the co-infected group of mice may delay parasite
clearance during treatment [21].
Our understanding of the mechanisms by which interactions
between parasites occur is still limited. Recent studies have
proposed an immunologic hypothesis based upon the T cell
dichotomy [22–24]. If one considers that for each parasite or
pathogen, there is a corresponding protective T cell/cytokine
response; concomitant infection could lead to synergistic or
antagonistic T cell responses, dependent upon what kind of
response (Th1 or Th2) was induced by each parasite [20,22–25].
Synergistic responses could decrease the pathologic impact of
the infections, whereas antagonistic responses could exacerbate
the diseases [8]. The nature of immune responses may vary
according to the stage and intensity of infections [16,22–24].
This could explain the slower P. berghei development and
decreased malaria parasitaemia observed during the chronic
stage of S. haematobium infection. Therefore, the observed
disparity in the parasitaemia may be attributed to the effect of
nature of immune response mounted against the parasite by
the host, which may vary according to the stage and intensity
of infections [19,23–25].
One interesting ﬁnding of this work is that post-infection
survivability of mice co-infected with S. haematobium and
P. berghei enhanced survival of mice. The co-infected mice
survived longer than the mono infected mice. The observed
disparity in our experimental outcomes from different studiesmay have resulted from differences in Plasmodium and schis-
tosome species used in the various studies, the potency of
S. haematobium during co-infection and differences in the dose
of S. haematobium cercariae used to infect the mice. Although
Bucher et al. [10], reported that the presence of chronic
S. mansoni infection did not inﬂuence the survival of
P. berghei infected mice. The data obtained in the present
study showed that chronic S. haematobium–P. berghei co-
infected mice survived for longer period of days than the
P. berghei mono-infected mice.
The co-infection of mice with P. berghei during acute
S. haematobium infection resulted in rapid P. berghei develop-
ment and increased in parasitaemia accompanied with enhanced
survivability of the mice. However, co-infection of mice with
P. berghei during chronic S. haematobium infection resulted in
slower P. berghei development and decreased malaria para-
sitaemia but similarly enhanced survivability of the mice.
Therefore, pre-existing chronic S. haematobium infection may
provide some protection to the host by reducing parasitaemia.
We recommend that further studies are done to measure some
immune parameters to clarify the immunoregulatory mechanism
that occurs during the process of co-infection.
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